Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Prophase Labs Inc PRPH

ProPhase Labs, Inc. is a biopharma, genomics, and diagnostics company. The Company provides whole genome sequencing solutions, while developing potential diagnostics and therapeutics in the fight against cancer. This includes a potentially life-saving cancer test focused on early detection of esophageal cancer and potential breakthrough cancer therapeutics with novel mechanisms of action. Its... see more

Recent & Breaking News (NDAQ:PRPH)

ProPhase Labs Exceeding Initial Goals as Covid-19 Lab Testing Business Ramps up

GlobeNewswire February 1, 2021

ProPhase Labs Announces Opening of Large CLIA Lab Covid Testing Facility in Garden City, New York

GlobeNewswire January 29, 2021

ProPhase Labs, Inc. Announces Closing of Public Offering

GlobeNewswire January 21, 2021

ProPhase Labs Announces Pricing of Public Offering of Common Stock

GlobeNewswire January 18, 2021

ProPhase Labs Announces Proposed Public Offering of Common Stock

GlobeNewswire January 15, 2021

ProPhase Labs to Present at the NobleCon17 Annual Small & Microcap Investor Conference on Tuesday, January 19, 2021 at 12:45 p.m. Eastern Time

GlobeNewswire January 11, 2021

ProPhase Labs Announces $5.5 Million Registered Direct Offering of Common Stock and Warrants

GlobeNewswire January 5, 2021

ProPhase Labs Expands COVID-19 Testing Capacity with New 25,000 Square Feet Testing Facility in Garden City, New York

GlobeNewswire December 8, 2020

ProPhase Labs Reports Financial Results for the Three and Nine Months Ended September 30, 2020

GlobeNewswire November 16, 2020

ProPhase Labs to Present at the Virtual Fall Investor Summit on Monday, November 16, 2020 at 2:30 p.m. Eastern Time

GlobeNewswire November 10, 2020

ProPhase Labs Completes Acquisition of CLIA Accredited Lab and Provides Corporate Update

GlobeNewswire November 2, 2020

ProPhase Labs Announces Definitive Agreement to Acquire CLIA Accredited Lab Certified for COVID-19 and Upper Respiratory Testing

GlobeNewswire October 23, 2020

ProPhase Labs Engages Industry Expert to Advise on Possible Acquisition of CLIA Accredited Labs Certified for COVID-19 and Other Testing

GlobeNewswire September 30, 2020

ProPhase Labs Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communication Program

GlobeNewswire September 30, 2020

ProPhase Labs Announces At-The-Market Equity Facility

GlobeNewswire September 23, 2020

ProPhase Labs Announces $10 Million Unsecured Debt Financing

GlobeNewswire September 18, 2020

ProPhase Labs Reports Financial Results for the Three and Six Months Ended June 30, 2020

GlobeNewswire August 11, 2020

ProPhase Labs Reports Financial Results for the Three Months Ended March 31, 2020

GlobeNewswire May 12, 2020

ProPhase Labs Reports Financial Results for the Year Ended December 31, 2019

GlobeNewswire March 25, 2020

PROPHASE LABS, INC. ANNOUNCES SPECIAL CASH DIVIDEND

GlobeNewswire November 20, 2019